Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Current treatments for alopecia show no significant long-term benefits.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.